A summary of the world-wide clinical investigations of recombinant factor VIII.
作者信息
Schwartz R S, Rousell R H
机构信息
Cutter Biological, Miles Inc., Berkeley, CA 94701.
出版信息
Semin Hematol. 1991 Apr;28(2 Suppl 1):53-4.
PMID:1908130
Abstract
摘要
相似文献
1
A summary of the world-wide clinical investigations of recombinant factor VIII.重组凝血因子VIII的全球临床研究综述。
Semin Hematol. 1991 Apr;28(2 Suppl 1):53-4.
2
Design of clinical studies with recombinant factor VIII. The rFactor VIII Clinical Trial Group.重组因子VIII临床研究的设计。重组因子VIII临床试验组。
Semin Hematol. 1991 Apr;28(2 Suppl 1):27-8.
3
Clinical efficacy of recombinant factor VIII. The rFactor VIII Clinical Trial Group.
Semin Hematol. 1991 Apr;28(2 Suppl 1):47-51.
4
Comments on adverse reactions with recombinant factor VIII.关于重组凝血因子VIII不良反应的评论
Semin Hematol. 1991 Apr;28(2 Suppl 1):43.
5
Clinical safety of recombinant factor VIII. The rFactor VIII Clinical Trial Group.重组因子VIII的临床安全性。重组因子VIII临床试验组。
Semin Hematol. 1991 Apr;28(2 Suppl 1):37-42.
6
The pharmacokinetics of recombinant factor VIII. The rFactor VIII Clinical Trial Group.重组凝血因子VIII的药代动力学。重组凝血因子VIII临床试验组。
Semin Hematol. 1991 Apr;28(2 Suppl 1):29-35; discussion 36.
7
Impact of recombinant factor VIII on hemophilia care.重组凝血因子VIII对血友病治疗的影响。
Vox Sang. 1994;67 Suppl 3:49-52. doi: 10.1111/j.1423-0410.1994.tb04543.x.
8
Immunologic safety of recombinant factor VIII. The rFactor VIII Clinical Trial Group.
Semin Hematol. 1991 Apr;28(2 Suppl 1):44.
9
Comments on the development of inhibitor antibodies in patients using recombinant factor VIII concentrates.关于使用重组凝血因子VIII浓缩剂的患者中抑制性抗体产生情况的评论
Semin Hematol. 1991 Apr;28(2 Suppl 1):45-6.
10
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A.人重组DNA衍生的抗血友病因子（凝血因子VIII）用于治疗甲型血友病。
Zhonghua Yi Xue Za Zhi (Taipei). 1999 Jul;62(7):450-4.
Zotero 插件